In this review, we primarily focused on the non-canonical immunomodulatory functions of AMPs against Gram-positive opportunistic bacteria in skin infections, which might provide a potent avenue for shaping host-directed therapeutics against, specially, the multi-drug drug-resistant varieties of such bacteria. The gene discussed is ADSL; the disease is skin infection.